Progyny Inc (PGNY)
13.72
-0.26
(-1.86%)
USD |
NASDAQ |
Nov 15, 09:49
Progyny Cash and Short Term Investments (Quarterly): 262.19M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 262.19M |
March 31, 2024 | 371.83M |
December 31, 2023 | 371.09M |
September 30, 2023 | 335.55M |
June 30, 2023 | 282.50M |
March 31, 2023 | 207.89M |
December 31, 2022 | 189.30M |
September 30, 2022 | 140.99M |
June 30, 2022 | 122.38M |
March 31, 2022 | 105.68M |
December 31, 2021 | 119.42M |
Date | Value |
---|---|
September 30, 2021 | 114.31M |
June 30, 2021 | 93.97M |
March 31, 2021 | 106.92M |
December 31, 2020 | 109.30M |
September 30, 2020 | 104.96M |
June 30, 2020 | 91.38M |
March 31, 2020 | 91.63M |
December 31, 2019 | 80.38M |
September 30, 2019 | 7.664M |
June 30, 2019 | 0.298M |
December 31, 2018 | 0.127M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
80.38M
Minimum
Dec 2019
371.83M
Maximum
Mar 2024
173.77M
Average
119.42M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Delcath Systems Inc | 13.99M |
Star Equity Holdings Inc | 6.29M |
Exact Sciences Corp | 1.021B |
Illumina Inc | 939.00M |
CytoSorbents Corp | 5.685M |